(PDF) MB4-2 Breakpoint in MMSET Combined With Del(17p)

MB4-2 Breakpoint in MMSET Combined With Del(17p) Defines a Subset of T(4;14) Multiple Myeloma With Very Poor Prognosis

Haematologica - Italy

doi 10.3324/haematol.2015.127001

Full Text

Abstract

Available in full text

Categories

Date

July 23, 2015

Authors

Publisher

Ferrata Storti Foundation (Haematologica)

Related search

High Sub-Clonal Fraction of 17p Deletion Is Associated With Poor Prognosis in Multiple Myeloma

English

Diagnostic Evaluation of T(4;14) in Multiple Myeloma and Evidence for Clonal Evolution

Cancer Research

English

MYEOV (Myeloma Overexpressed (In a Subset of T(11;14) Positive Multiple Myelomas))

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Cancer Research

English

Epstein-Barr Virus Infection Is Associated With Clinical Characteristics and Poor Prognosis of Multiple Myeloma

Bioscience Reports

Molecular Biology

English

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy

Cancer Research

Molecular Medicine

Molecular Biology

English

CHIR-258, a Novel, Multitargeted Tyrosine Kinase Inhibitor for the Potential Treatment of T(4;14) Multiple Myeloma

English

CA 125 Half-Life Breakpoint Between a “Good” and “Poor” Prognosis in Patients With Ovarian Cancer

International Journal of Gynecology and Obstetrics

English

Psy122 - Management of Poor Prognosis Multiple Myeloma Patients Under Regular Clinical Conditions in Spain

Value in Health

Occupational Health

English

HAX-1 Overexpression in Multiple Myeloma Is Associated With Poor Survival

British Journal of Haematology

English